A highly secreted sulphamidase engineered to cross the blood‐brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA

EMBO Molecular Medicine

Nicolina Cristina Sorrentino²  Luca D'Orsi²  Irene Sambri²  Edoardo Nusco²  Ciro Monaco²  Carmine Spampanato²  Elena Polishchuk¹  Paola Saccone²  Elvira De Leonibus²  Andrea Ballabio² 

[1]Institute of Genetics and Biophysics (IGB), Naples, Italy

[2]Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy

关键词: blood‐brain barrier;    CNS therapy;    lysosomal storage disorders;    MPS‐IIIA;    sulphamidase;   

DOI  :  10.1002/emmm.201202083

来源: Wiley

【 摘 要 】

Abstract

Mucopolysaccharidoses type IIIA (MPS-IIIA) is a neurodegenerative lysosomal storage disorder (LSD) caused by inherited defects of the sulphamidase gene. Here, we used a systemic gene transfer approach to demonstrate the therapeutic efficacy of a chimeric sulphamidase, which was engineered by adding the signal peptide (sp) from the highly secreted iduronate-2-sulphatase (IDS) and the blood-brain barrier (BBB)-binding domain (BD) from the Apolipoprotein B (ApoB-BD). A single intravascular administration of AAV2/8 carrying the modified sulphamidase was performed in adult MPS-IIIA mice in order to target the liver and convert it to a factory organ for sustained systemic release of the modified sulphamidase. We showed that while the IDS sp replacement results in increased enzyme secretion, the addition of the ApoB-BD allows efficient BBB transcytosis and restoration of sulphamidase activity in the brain of treated mice. This, in turn, resulted in an overall improvement of brain pathology and recovery of a normal behavioural phenotype. Our results provide a novel feasible strategy to develop minimally invasive therapies for the treatment of brain pathology in MPS-IIIA and other neurodegenerative LSDs.

→See accompanying article emmm.201302668

【 授权许可】

CC BY   
Copyright © 2013 EMBO Molecular Medicine

Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.